Jump to content

Bimuno: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Coast123 (talk | contribs)
257 edits
→‎Bimuno Food Supplement: amended citations
Coast123 (talk | contribs)
257 edits
Line 49: Line 49:
==Patents and Trademarks==
==Patents and Trademarks==


Bimuno's formulation, technology, production and brand positioning are all recognised and protected by worldwide patents and trademarks.<ref>{{cite web|url=http://www.bimuno.com/about-us/bimuno-research-and-clinical-trials/ |title=Bimuno About Us |date= |accessdate=2015-11-16}}</ref>
Bimuno's formulation, technology, production and brand positioning are all recognised and protected by worldwide patents and trademarks.<ref>{{cite web|url=http://www.clasado.com/why-bimuno/ |title=Why Bimuno? |date= |accessdate=2015-11-16}}</ref>


==Research and Development==
==Research and Development==

Revision as of 16:26, 10 December 2015

Bimuno
Company typeBiotechnology Developer
Founded2004
HeadquartersJersey, Channel Islands UK
ParentClasado BioSciences Ltd
Websitehttp://www.bimuno.com/

Bimuno is a bio-engineered second generation Prebiotic (nutrition)[1] food supplement. The prebiotic supplement was developed by Clasado BioSciences, an international Biotechnology company based in Jersey, UK.[2]

Bimuno and The University of Reading, UK

The concept of prebiotics was first described by Glenn Gibson, (then at the Institute of Food Research, Reading) and Marcel Roberfroid (at the University Catholique Louvain, Belguim) in 1995.[3] As Professor of Food Microbiology at the University of Reading in 1999,[4] Gibson has continued his work on prebiotics, including the development of Bimuno - a prebiotic for use in humans.[5] The Bimuno development programme combined Gibson’s research on prebiotics with Professor Bob Rastall’s (Department of Food and Nutritional Sciences, 1994 – present) research on enzymic development of functional food ingredients.[6]

Bimuno Food Supplement

Bimuno is a Dietary supplement containing Galactooligosaccharides (β-Galacto-Oligosaccharide).[7]

β-Galacto-Oligosaccharide (Bimuno®) is one of a group of nutrient fibres (Oligosaccharides). Oligosaccarides feed and cultivate certain types of friendly Bacteria found in the gut.[8][9][10][11][12][13][14][15]

Bimuno Powder Ingredients

  • Each sachet contains 5.5g of powder.[16]
  • The active ingredient is galacto-oligosaccharides, equivalent to a dose of 2.75g.[17]
  • The Lactose content is 1.5g[18]
  • Per dose it contains 15 kcal, 1.9g of sugar and 0.03g of fat.[19]

Patents and Trademarks

Bimuno's formulation, technology, production and brand positioning are all recognised and protected by worldwide patents and trademarks.[20]

Research and Development

According to the manufacturer's website, Bimuno is the result of research and development including Peer reviews and Clinical trials conducted in collaboration with the University of Reading’s Food Microbial Sciences Unit and other global research institutes.[21]

Parent Company

Clasado BioSciences is an International Biotechnology company headquartered on the island of Jersey in The Channel Islands.[22]

Clasado BioSciences researches and develops galacto-oligosaccharide (GOS) products for Food, Healthcare and Pharmaceutical companies.[23]

  • Formed 2004[24]
  • Offices in Asia, Europe and USA[25]

Clasado BioSciences are developers and manufacturers of prebiotic technologies.[26]

References

  1. ^ "A gut feeling" (PDF). Retrieved 2015-11-16.
  2. ^ "Clasado About Us". Retrieved 2015-11-16.
  3. ^ "Development of a new prebiotic product (Bimuno) - from research to retail". Retrieved 2015-11-16.
  4. ^ "Staff Profile:Professor Glenn Gibson". Retrieved 2015-11-16.
  5. ^ "Staff Profile:Professor Glenn Gibson". Retrieved 2015-11-16.
  6. ^ "BIMUNO RESEARCH AND CLINICAL TRIALS". Retrieved 2015-11-16.
  7. ^ "Case Study Contract Research:Developing a Prebiotic product" (PDF). Retrieved 2015-11-16.
  8. ^ Bouhnik Y, Raskine L, Simoneau G; et al. (December 2004). ""The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study"". Am. J. Clin. Nutr. 80 (6): 1658–64. PMID 15585783. {{cite journal}}: Explicit use of et al. in: |last= (help)CS1 maint: multiple names: authors list (link)
  9. ^ Ito M., Deguchi Y., Matsumoto K., Kimura M. Onodera, Yajima T. (1993). ""Influence of galactooligosaccharides on the human fecal microflora"". J Nutr Sci Vitaminol 39: 635–640. doi:10.3177/jnsv.39.635.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  10. ^ Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (March 2009). "Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome". Aliment. Pharmacol. Ther. 29 (5): 508–18. doi:10.1111/j.1365-2036.2008.03911.x. PMID 19053980.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  11. ^ Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR (November 2008). ""Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers". Am. J. Clin. Nutr. 88 (5): 1438–46. PMID 18996881". {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)
  12. ^ Ben XM, Zhou XY, Zhao WH; et al. (June 2004). ""Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants". Chin. Med. J. 117 (6): 927–31.PMID 15198901". {{cite journal}}: Cite journal requires |journal= (help); Explicit use of et al. in: |last= (help)CS1 maint: multiple names: authors list (link)
  13. ^ Boehm G, Lidestri M, Casetta P; et al. (May 2002). ""Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants"". Arch. Dis. Child. Fetal Neonatal Ed. 86 (3): F178–81. doi:10.1136/fn.86.3.f178. PMC 1721408. PMID 11978748. {{cite journal}}: Explicit use of et al. in: |last= (help)CS1 maint: multiple names: authors list (link)
  14. ^ Fanaro S, Marten B, Bagna R; et al. (January 2009). ""Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study"". J. Pediatr. Gastroenterol. Nutr. 48 (1): 82–8. doi:10.1097/MPG.0b013e31817b6dd2. PMID 19172129. {{cite journal}}: Explicit use of et al. in: |last= (help)CS1 maint: multiple names: authors list (link)
  15. ^ Napoli JE, Brand-Miller JC, Conway P (November 2003). ""Bifidogenic effects of feeding infant formula containing galacto-oligosaccharides in healthy formula-fed infants"". Asia Pac J Clin Nutr 12 (Suppl): S60. PMID 15023687.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ^ "Product description". Retrieved 2015-11-16.
  17. ^ "Product description". Retrieved 2015-11-16.
  18. ^ "Product description". Retrieved 2015-11-16.
  19. ^ "Product description". Retrieved 2015-11-16.
  20. ^ "Why Bimuno?". Retrieved 2015-11-16.
  21. ^ Depeint; et al. (2008). "Prebiotic evaluation of a novel galactooligosaccharide mixture (B-GOS) produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study". American Journal of Clinical Nutrition 87: 785–91. {{cite journal}}: Explicit use of et al. in: |last= (help)
  22. ^ "Clasado About Us". Retrieved 2015-11-16.
  23. ^ "Clasado About Us". Retrieved 2015-11-16.
  24. ^ "Clasado About Us". Retrieved 2015-11-16.
  25. ^ "Clasado About Us". Retrieved 2015-11-16.
  26. ^ "Clasado About Us". Retrieved 2015-11-16.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bimuno&oldid=694647738"